IE42793L - Treatment of colitis - Google Patents

Treatment of colitis

Info

Publication number
IE42793L
IE42793L IE760749A IE74976A IE42793L IE 42793 L IE42793 L IE 42793L IE 760749 A IE760749 A IE 760749A IE 74976 A IE74976 A IE 74976A IE 42793 L IE42793 L IE 42793L
Authority
IE
Ireland
Prior art keywords
colitis
treatment
Prior art date
Application number
IE760749A
Other versions
IE42793B1 (en
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of IE42793L publication Critical patent/IE42793L/en
Publication of IE42793B1 publication Critical patent/IE42793B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/78Polymers containing oxygen of acrylic acid or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
IE749/76A 1975-04-09 1976-04-09 Preparation for treatment of colitis IE42793B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7504049A SE7504049L (en) 1975-04-09 1975-04-09 COLON PREPARATION

Publications (2)

Publication Number Publication Date
IE42793L true IE42793L (en) 1976-10-09
IE42793B1 IE42793B1 (en) 1980-10-22

Family

ID=20324216

Family Applications (1)

Application Number Title Priority Date Filing Date
IE749/76A IE42793B1 (en) 1975-04-09 1976-04-09 Preparation for treatment of colitis

Country Status (12)

Country Link
BE (1) BE840552A (en)
DE (1) DE2614296A1 (en)
DK (1) DK153376A (en)
FI (1) FI56772C (en)
FR (1) FR2306710A1 (en)
GB (1) GB1538123A (en)
IE (1) IE42793B1 (en)
LU (1) LU74732A1 (en)
NL (1) NL7603600A (en)
NO (1) NO761101L (en)
NZ (1) NZ180552A (en)
SE (1) SE7504049L (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52139715A (en) * 1976-05-14 1977-11-21 Nippon Kayaku Co Ltd Coated granules of alkali polyacrylate
FR2471186A1 (en) * 1979-12-10 1981-06-19 Roussel Uclaf NEW COLIC DELITESCENCE TABLETS AND THEIR PREPARATION PROCESS
US4444761A (en) * 1981-05-04 1984-04-24 Syntex (U.S.A.) Inc. Cellulose/carboxymethyl cellulose mixtures useful for controlling fecal output, and methods employing them
US4522804A (en) * 1983-01-03 1985-06-11 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of propranolol
US4461759A (en) * 1983-01-03 1984-07-24 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of veropamil
US4521401A (en) * 1983-01-03 1985-06-04 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of quinidine
DE3776116D1 (en) * 1986-12-30 1992-02-27 American Cyanamid Co COMPOSITION CONTAINING A POLYCARBOPHIL.
GB8817015D0 (en) * 1988-07-16 1988-08-17 Reckitt & Colmann Prod Ltd Method of treatment
FR2636532B1 (en) * 1988-09-20 1993-11-19 Glaxo Group Ltd PHARMACEUTICAL COMPOSITIONS
IL98087A (en) * 1990-05-04 1996-11-14 Perio Prod Ltd Colonic drug delivery system
HU210497B (en) * 1990-05-04 1995-04-28 Perio Prod Ltd Process for production of modified pectin
DE9212938U1 (en) * 1992-09-25 1992-11-26 Boehringer Ingelheim Gmbh, 6507 Ingelheim, De
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
MX2019012086A (en) 2017-04-14 2021-01-08 Gelesis Llc Compositions and methods for treating or preventing gut permeability-related disorders.

Also Published As

Publication number Publication date
DE2614296A1 (en) 1976-10-21
FI760948A (en) 1976-10-10
NL7603600A (en) 1976-10-12
BE840552A (en) 1976-10-11
NZ180552A (en) 1978-07-28
GB1538123A (en) 1979-01-10
FI56772C (en) 1980-04-10
IE42793B1 (en) 1980-10-22
SE7504049L (en) 1976-10-10
FR2306710A1 (en) 1976-11-05
FI56772B (en) 1979-12-31
FR2306710B1 (en) 1979-07-13
LU74732A1 (en) 1977-02-04
NO761101L (en) 1976-10-12
DK153376A (en) 1976-10-10

Similar Documents

Publication Publication Date Title
ZA765406B (en) Treatment of small articles
GB1550835A (en) Treatment of tobacco
AU2076476A (en) Aracterizat-ion of bodies
GB1543157A (en) Treatment of fibres
ZA767653B (en) Treatment of waste
ZA764855B (en) Treatment of pigment
GB1540441A (en) Treatment of blood plasma
ZA764072B (en) Treatment of solid-liquid-gas mixtures
ZA763339B (en) Treatment of pigment
ZA764653B (en) Treatment of endotoxaemia
IE42793L (en) Treatment of colitis
GB1554283A (en) Treatment of glass
JPS5210834A (en) Surface treatment of metal
ZA762669B (en) Treatment of neoplasias
JPS5212976A (en) Treatment of unicellular preotein
ZA763340B (en) Treatment of pigment
JPS51139618A (en) Treatment of animal
ZA765733B (en) Treatment of effluent
JPS5218810A (en) Complex medical composition of estrogennprostaglangin
ZA762513B (en) Treatment of tire making components
JPS5242997A (en) Treatment of wool
GB1547293A (en) Treatment of materials with organo-halosilanes
PH12349A (en) Treatment of seedlings
ZA765293B (en) Treatment of electrodes
JPS51120940A (en) Surface treatment of metals